Investigational Drug Information for Tradipitant
✉ Email this page to a colleague
What is the development status for investigational drug Tradipitant?
Tradipitant is an investigational drug.
There have been 13 clinical trials for Tradipitant.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 20th 2019.
The most common disease conditions in clinical trials are Motion Sickness, Eczema, and Dermatitis, Atopic. The leading clinical trial sponsors are Vanda Pharmaceuticals, Mayo Clinic, and Cross Research S.A.
There are fifteen US patents protecting this investigational drug and one hundred and sixty-four international patents.
Summary for Tradipitant
| US Patents | 15 |
| International Patents | 164 |
| US Patent Applications | 66 |
| WIPO Patent Applications | 51 |
| Japanese Patent Applications | 10 |
| Clinical Trial Progress | Phase 3 (2019-08-20) |
| Vendors | 46 |
Recent Clinical Trials for Tradipitant
| Title | Sponsor | Phase |
|---|---|---|
| Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness | Vanda Pharmaceuticals | Phase 3 |
| Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness | Vanda Pharmaceuticals | Phase 3 |
| Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Tradipitant for Functional Dyspepsia | Mayo Clinic | Phase 2 |
Clinical Trial Summary for Tradipitant
Top disease conditions for Tradipitant
Top clinical trial sponsors for Tradipitant
US Patents for Tradipitant
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tradipitant | ⤷ Sign Up | Intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4- -yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone | ELI LILLY AND COMPANY (Indianapolis, IN) | ⤷ Sign Up |
| Tradipitant | ⤷ Sign Up | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Sign Up |
| Tradipitant | ⤷ Sign Up | Process development of a pyridine-containing NK-1 receptor antagonist | ELI LILLY AND COMPANY (Indianapolis, IN) | ⤷ Sign Up |
| Tradipitant | ⤷ Sign Up | Method of treatment with tradipitant | VANDA PHARMACEUTICALS INC. (Washington, DC) | ⤷ Sign Up |
| Tradipitant | ⤷ Sign Up | ⤷ Sign Up | ||
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tradipitant
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tradipitant | Australia | AU2007337255 | 2026-12-20 | ⤷ Sign Up |
| Tradipitant | Brazil | BRPI0721069 | 2026-12-20 | ⤷ Sign Up |
| Tradipitant | Canada | CA2671770 | 2026-12-20 | ⤷ Sign Up |
| Tradipitant | China | CN101568523 | 2026-12-20 | ⤷ Sign Up |
| Tradipitant | Cyprus | CY1115270 | 2026-12-20 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
